Prevention of new vascular events in patients with brain infarction or peripheral embolism and thoracic aortic plaques >=4mm in thickness in the aortic arch or descending aortic upstream to the embolized artery.

Trial Profile

Prevention of new vascular events in patients with brain infarction or peripheral embolism and thoracic aortic plaques >=4mm in thickness in the aortic arch or descending aortic upstream to the embolized artery.

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Apr 2014

At a glance

  • Drugs Aspirin; Clopidogrel; Warfarin
  • Indications Stroke; Thromboembolism
  • Focus Therapeutic Use
  • Acronyms ARCH
  • Most Recent Events

    • 03 Apr 2014 Results published in the Stroke.
    • 01 Jul 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
    • 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top